Abstract:Background: Primary biliary cholangitis (PBC) is a chronic intrahepatic cholestatic autoimmune liver disease characterized by inflammatory injury of small and medium-sized bile ducts in the liver. The pathogenesis of PBC has yet to be entirely understood. CD47/signal-regulatory protein alpha (SIRPα) is closely related to developing autoimmune diseases by promoting inflammatory response. However, the effect of CD47/SIRPα on inflammatory response in PBC patients is still unclear. Objective: We investigated the expression of CD47/SIRPα and the effect of inflammatory cytokines on the CD47 expression, analyzed potential autoantibodies against CD47 and the effect of anti-CD47 antibody on the inflammatory response in PBC, provided laboratory basis for the study of the pathogenesis and targets for non-invasive diagnosis and treatment on PBC. Methods: The expression levels of CD47 and SIRPα on peripheral blood mononuclear cells (PBMC) were measured in 14 patients with PBC (the PBC group) and 13 healthy subjects (the Control group) by flow cytometry (FCM). The PBMC derived from healthy subjects were stimulated with healthy subjects' serum, PBC patients' serum, IFN-α or TNF-α, and the CD47 expression level on CD14 + monocytes was detected by FCM. The level of serum anti-CD47 antibody or IFN-α in PBC patients and healthy subjects was analyzed by ELISA. FCM was used to examine the TNF-α expression level in CD14 + monocytes of healthy subjects stimulated with isotype control antibody, anti-CD47 antibody, LPS or LPS combined with CD47 antibody. Results: The CD47 expression level on the CD14 + monocytes in PBC patients was statistically higher than that in the Control group ( P <0.01). Compared with the Control group (PBMC+healthy serum), the CD47 expression on CD14 + monocyte stimulated with the PBC patients' serum (PBMC+PBC patients' serum) was increased ( P <0.001); the CD47 expression on CD14 + monocyte stimulated with IFN-α (PBMC + IFN-α) increased gradually with the increased concentration of IFN-α ( P <0.05). However, there was no similar trend on CD14 + monocyte stimulated with the TNF-α (PBMC+TNF-α) ( P >0.05). The levels of serum anti-CD47 antibody and IFN-α in the PBC patients were higher than those in healthy subjects ( P <0.05). The TNF-α expression level in CD14 + monocyte stimulated with the LPS (PBMC+LPS) or anti-CD47 antibody+LPS group (PBMC+LPS+anti-CD47 antibody) was significantly increased than that in the Control group (PBMC+isotype control antibody) ( P <0.01 and P <0.001, respectively). The TNF-α expression level in CD14 + monocyte stimulated with the anti-CD47 antibody + LPS was higher than that with the LPS ( P < 0.05). Conclusion: The CD47 may be related to the pathogenesis of PBC by inflammatory response. The CD47/SIRPα signal were imbalanced in PBC patients. The presence of serum anti-CD47 antibodies in PBC patients provides a laboratory basis for clinical diagnosis and treatment.

FcγRIIB expression increases during primary biliary cholangitis

Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis.

Clinical Analysis of Primary Biliary Cirrhosis: a Report of 31 Cases

IL-17A produced by invariant natural killer T cells and CD3(+)CD56(+)alpha Galcer-CD1d tetramer(-) T cells promote liver fibrosis in patients with primary biliary cholangitis

IL-17A produced by invariant natural killer T cells and CD3+CD56+αGalcer-CD1d tetramer– T cells promote liver fibrosis in patients with primary biliary cholangitis

Increased Numbers of Circulating ICOS + Follicular Helper T and CD38 + Plasma Cells in Patients with Newly Diagnosed Primary Biliary Cirrhosis

Soluble Immune Checkpoints Are Elevated in Patients with Primary Biliary Cholangitis

Increased Il-23 and Il-17 Expression by Peripheral Blood Cells of Patients with Primary Biliary Cirrhosis

Regulation of CD47 expression on CD14+ monocytes by interferon-α in PBC patients

Increased Levels of Chemokine Receptor CXCR3 and Chemokines IP-10 and MIG in Patients with Primary Biliary Cirrhosis and Their First Degree Relatives.

Bile acid receptor agonists in primary biliary cholangitis: Regulation of the cholangiocyte secretome and downstream T cell differentiation

Unique DUOX2+ACE2+ small cholangiocytes are pathogenic targets for primary biliary cholangitis

Implication of Increased Serum IL-31 for Primary Biliary Cholangitis.

Dysregulation of Peritoneal Cavity B1a Cells and Murine Primary Biliary Cholangitis

Clonal Characteristics of Circulating B Lymphocyte Repertoire in Primary Biliary Cholangitis

CD4+ CD25+ but not CD4+ Foxp3+ T cells as a regulatory subset in primary biliary cirrhosis.

Lower Plasma Levels of IL-35 in Patients with Primary Biliary Cirrhosis.

RANK/RANKL Acts as a Protective Factor by Targeting Cholangiocytes in Primary Biliary Cholangitis

[Study on Association of BAFF Receptors Gene Expression and Primary Biliary Cirrhosis].

Does HLA-G play a role in PBC?

Expression of Siglec-1 mRNA in Monocytes from Patients with Primary Biliary Cirrhosis and Its Clinical Significance